Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fusion Medical preparing for clinical study of flowable gel to stop heavy surgical bleeding.

This article was originally published in The Gray Sheet

Executive Summary

FUSION MEDICAL'S FLOWABLE GEL COLLAGEN SEALANT CLINICAL TRIALS for cardiovascular and general surgery are slated to commence during the second quarter, Philip Sawyer, president and CEO of Fusion Medical Technologies said at a March 25 New York Society of Security Analysts meeting in New York City. The collagen-based sealant can stop active bleeding in approximately one minute, the company claims.
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT007798

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel